$6.28 0.07 (+1.13%)
12/4/2009 9:32 AM

Elan Corp, plc (ADR) (ELN)

CAPS Rating: 4 out of 5

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Recs

1
Member Avatar adambutz (30.17) Submitted: 6/1/2009 9:22:14 AM : Outperform Start Price: $8.00 ELN Score: -41.45

Takeover target by Bristol Myers!

Report this Post 0 Comments

Featured Broker Partners